NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | -58.7% | 48,900 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $126 | -77.2% | 48,900 | -63.9% | 0.00% | 0.0% |
Q1 2023 | $552 | +144.2% | 135,300 | +200.0% | 0.00% | 0.0% |
Q4 2022 | $226 | -100.0% | 45,100 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $589,000 | -2.6% | 45,100 | -4.4% | 0.00% | 0.0% |
Q2 2022 | $605,000 | -11.5% | 47,200 | +5.1% | 0.00% | 0.0% |
Q1 2022 | $684,000 | -14.0% | 44,900 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $795,000 | +14.4% | 44,900 | +35.6% | 0.00% | 0.0% |
Q3 2021 | $695,000 | -15.2% | 33,100 | -20.4% | 0.00% | 0.0% |
Q2 2021 | $820,000 | +24.4% | 41,600 | +83.3% | 0.00% | +50.0% |
Q1 2021 | $659,000 | +42.3% | 22,700 | +48.4% | 0.00% | 0.0% |
Q4 2020 | $463,000 | +90.5% | 15,300 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $243,000 | -19.5% | 15,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $302,000 | +85.3% | 15,300 | +15.0% | 0.00% | 0.0% |
Q1 2020 | $163,000 | -33.5% | 13,300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $245,000 | +410.4% | 13,300 | +269.4% | 0.00% | – |
Q3 2019 | $48,000 | +84.6% | 3,600 | +100.0% | 0.00% | – |
Q2 2019 | $26,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |